HOME >> MEDICINE >> NEWS
Chronic pain treatments more effective when taken together, new study shows

People suffering from chronic, debilitating pain caused by nerve damage or disease report better pain relief at lower doses of a combined drug treatment than from either drug administered individually, a new Queen's study funded by the Canadian Institutes of Health Research (CIHR) shows.

When given a combination of the anti-seizure drug gabapentin and the opioid morphine, patients with two different types of neuropathic pain experienced lower pain intensity than when they received either of the drugs individually. As well, significantly lower doses of gabapentin and morphine were required during combination treatment than during treatment with either drug alone.

"We now have the first clinical evidence that combining these drugs provides better pain relief, with comparable side effects," says lead researcher Dr. Ian Gilron, Director of Clinical Pain Research for Queen's Departments of Anesthesiology, and Pharmacology & Toxicology, and an anesthesiologist at Kingston General Hospital. "This new treatment approach has the potential to dramatically improve quality of life for people suffering from neuropathic pain, a condition that has puzzled health care workers for years because it is often experienced in areas of the body which appear uninjured."

Results of the study will be published in the March 31 edition of the New England Journal of Medicine.

Also on the team from Queen's are Joan Bailey (Anesthesiology), Dongsheng Tu (Mathematics and Statistics), Ronald Holden (Psychology,) Robyn Houlden (Medicine); and from Dalhousie University's Departments of Medicine and Chemistry, Donald Weaver.

"This is exciting news for the health research community in Canada," says Dr. Rmi Quirion, Scientific Director of CIHR's Institute of Neurosciences, Mental Health and Addiction. "It is a great achievement for Dr. Gilron and his team, but most importantly, it is a critical research finding for Canadians whose chronic pain may be eased by thi
'"/>

Contact: Nancy Dorrance
dorrance@post.queensu.ca
613-533-2869
Queen's University
31-Mar-2005


Page: 1 2 3

Related medicine news :

1. Chronic fatigue patients show lower response to placebos
2. Chronic back pain shrinks thinking parts of the brain, study finds
3. Chronic sinusitis sufferers have enhanced immune responses to fungi
4. Chronic diseases need global health attention
5. Chronic care medicine: Physicians say help!
6. Chronic fatigue syndrome and Gulf War veterans
7. Chronic stress researcher to speak at NCCAMs Distinguished Lecture Series
8. Chronic cough significantly impacts life quality in women
9. Chronic diseases linked to falls in elderly women
10. Chronic fatigue syndrome is rare in children
11. Chronic drinking increases cortisol during intoxication and withdrawal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2019)... , ... September 21, 2019 , ... ... that he has been certified by the American Academy of Facial Esthetics (AAFE) ... professional medical-grade skin care products. , Dr. Patel has also been certified by ...
(Date:9/18/2019)... YORK (PRWEB) , ... September 18, 2019 , ... DOROT hosts its annual Rosh Hashanah ... from which more than 700 volunteers will be heading out to visit our seniors. , ... , The Upper East Side, at Central Synagogue 123 East 55st Street , ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... winner Meb Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise ... Heart and Stroke Walk on Saturday, September 21 in Balboa Park alongside National ...
(Date:9/17/2019)... ... September 17, 2019 , ... Dr. Jacqueline ... laser dentistry . A minimally invasive approach to gum surgery, laser dentistry ... , Laser dentistry is gentle and effective because it simply uses laser light ...
(Date:9/17/2019)... CHICAGO (PRWEB) , ... September 17, 2019 , ... ... cocktail reception fundraiser. Gather for GRIN2B will be held at Found Kitchen ... p.m. , Proceeds will help fund research on GRIN2B-Related Neurodevelopmental Disorder, a rare condition ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... MILWAUKEE (PRWEB) , ... September 13, 2019 , ... The ... voted, based on the available safety and efficacy data, to recommend approval of a ... be Palforzia, but it was previously referred to as AR101. , The FDA would ...
(Date:9/14/2019)... ... September 14, 2019 , ... CME4Life, a leading provider ... announcing its attempt at a world record “Longest Medical Lecture” on November 16, ... while earning 30 CME credits in 30 consecutive hours. ?The conference will take ...
(Date:9/12/2019)... ... September 12, 2019 , ... Stratosphere Networks will ... will take place on Monday, October 7 at Found Kitchen and Social House in ... fund research on GRIN2B-Related Neurodevelopmental Disorder. GRIN2B is a gene on the short arm ...
Breaking Medicine Technology:
Cached News: